Granted Patent
B2
US 8,969,571 · App. 14/087,404 · Granted Mar 3, 2015
Biphenyl derivatives
Assignee:
Theravance Respiratory Company, LLC
C07D211/46A61K31/445A61K31/452C07D211/48C07D211/58C07D401/06C07D401/12C07D401/14C07D405/12C07D409/06C07D409/12C07D453/02C07D471/08G01N33/9433
View Patent ↗
Loading inventors, assignments & file history…
Abstract
This invention provides biphenyl derivatives of formula I: wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , W, a, b and c are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The biphenyl derivatives of this invention possess both β 2 adrenergic receptor agonist and muscarinic receptor antagonist activity and therefore, such biphenyl derivatives are useful for treating pulmonary disorders, such as chronic obstructive pulmonary disease and asthma.
Claims (3)
1. A compound of the formula:
2. A compound of the formula:
3. A compound of the formula:
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 12, 2020
From: THERAVANCE RESPIRATORY COMPANY, LLC
To: THERAVANCE BIOPHARMA R&D IP, LLC
Reel/Frame 054393/0695 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 23, 2014
From: THERAVANCE, INC.
To: THERAVANCE RESPIRATORY COMPANY, LLC
Reel/Frame 033371/0626 →
Continuity (8)
Provisional Application
60467035
· May 1, 2003
Provisional Application
60447843
· Feb 14, 2003